---
title: "Aoshikang Technology Co., Ltd. released its performance for the first half of the year, with a net profit attributable to the parent company of 196 million yuan, a year-on-year decrease of 11.96%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252672513.md"
description: "According to the Zhitong Finance APP, Aoshikang Technology Co., Ltd. released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 2.565 billion yuan, a year-on-year increase of 19.43%. The net profit attributable to shareholders of the listed company was 196 million yuan, a year-on-year decrease of 11.96%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 184 million yuan, a year-on-year decrease of 12.79%. The basic earnings per share were 0.62 yuan"
datetime: "2025-08-12T12:01:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252672513.md)
  - [en](https://longbridge.com/en/news/252672513.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252672513.md)
generator: "portal-rs"
---

# Aoshikang Technology Co., Ltd. released its performance for the first half of the year, with a net profit attributable to the parent company of 196 million yuan, a year-on-year decrease of 11.96%

According to the Zhitong Finance APP, Aoshikang Technology Co., Ltd. (002913.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 2.565 billion yuan, a year-on-year increase of 19.43%. The net profit attributable to shareholders of the listed company was 196 million yuan, a year-on-year decrease of 11.96%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 184 million yuan, a year-on-year decrease of 12.79%. The basic earnings per share were 0.62 yuan

### Related Stocks

- [002913.CN](https://longbridge.com/en/quote/002913.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [PFSE: Record Q2 revenue and profit growth, driven by strong demand and innovation in HVDC technology](https://longbridge.com/en/news/296308264.md)
- [HELP Therapeutics Announces Nature Medicine Has Published HiCM-188 Clinical Trial Data for Advanced Ischemic Heart Failure](https://longbridge.com/en/news/296448083.md)
- [TempraMed Announces Extension of Maccabi Healthcare Services Agreement | TMPTF Stock News](https://longbridge.com/en/news/296479419.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**